![Michelle LaSpaluto](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Michelle LaSpaluto formerly worked at AlphaVax, Inc., as Senior Director-Accounting from 2000 to 2011 and Chimerix, Inc., as Chief Financial Officer from 2023 to 2025.
Ms. LaSpaluto received her undergraduate degree from Michigan State University and Masters Business Admin degree from East Carolina University.
Eerdere bekende functies van Michelle LaSpaluto
| Bedrijven | Functie | Einde |
|---|---|---|
| CHIMERIX, INC. | Financieel Directeur/CFO | 21-04-2025 |
AlphaVax, Inc.
 AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology Developing a new vaccine technology with broad applications against infectious diseases | Comptroller/Controller/Auditor | 01-06-2011 |
Opleiding van Michelle LaSpaluto
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
41
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Chimerix, Inc.
 Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
Michigan State University
 Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
East Carolina University
 East Carolina University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AlphaVax, Inc.
AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology Developing a new vaccine technology with broad applications against infectious diseases | Health Technology |
Kies MarketScreener 
